Data-driven modeling for precision medicine in pediatric acute liver failure

Ruben Zamora, Yoram Vodovotz*, Qi Mi, Derek Barclay, Jinling Yin, Simon Horslen, David Rudnick, Kathleen M. Loomes, Robert H. Squires

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

34 Scopus citations


The absence of early outcome biomarkers for pediatric acute liver failure (PALF) hinders medical and liver transplant decisions. We sought to define dynamic interactions among circulating inflammatory mediators to gain insights into PALF outcome subgroups. Serum samples from 101 participants in the PALF study, collected over the first 7 d following enrollment, were assayed for 27 inflammatory mediators. Outcomes (spontaneous survivors [S, n = 61], nonsurvivors [NS, n = 12] and liver transplant patients [LTx, n = 28]) were assessed at 21 d post-enrollment. Dynamic interrelations among mediators were defined using data-driven algorithms. Dynamic Bayesian network inference identified a common network motif, with HMGB1 as a central node in all patient subgroups. The networks in S and LTx were similar, and differed from NS. Dynamic network analysis suggested similar dynamic connectivity in S and LTx, but a more highly interconnected network in NS that increased with time. A dynamic robustness index calculated to quantify how inflammatory network connectivity changes as a function of correlation stringency differentiated all three patient subgroups. Our results suggest that increasing inflammatory network connectivity is associated with nonsurvival in PALF and could ultimately lead to better patient outcome stratification.

Original languageEnglish
Pages (from-to)821-829
Number of pages9
JournalMolecular medicine (Cambridge, Mass.)
StatePublished - 2016
Externally publishedYes


Dive into the research topics of 'Data-driven modeling for precision medicine in pediatric acute liver failure'. Together they form a unique fingerprint.

Cite this